Log In
Print this Print this

HIV vaccine (gag/pol/nef) (732461)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHIV vaccine utilizing HIV gag, pol and nef proteins as immunogens
Molecular Target HIV gag polyprotein ; HIV p27 (nef)
Mechanism of ActionVaccine
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsPrevent or slow HIV-1 infection and AIDS
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today